Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2005-11-07 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GROIX (56590), Morbihan
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DELANGE METAYER : revenue, balance sheet and financial ratios
PHARMACIE DELANGE METAYER is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GROIX (56590),
this company of category PME
shows in 2024 a net income positive of 188 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DELANGE METAYER (SIREN 487474009)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
187 830 €
223 187 €
261 498 €
239 984 €
182 545 €
190 800 €
211 814 €
185 156 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
En 2024, PHARMACIE DELANGE METAYER genera un resultado neto positivo de 188 k€. Evolución 2017-2024: 185 k€ -> 188 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
187 830 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 24%. Este nivel muy bajo refleja una estructura financiera sólida. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 76%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
24.33%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
75.73%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
7.383
4.447
4.338
2.51
0.992
0.267
17.997
24.33
Financial autonomy
88.485
90.29
89.786
90.662
91.008
92.018
74.584
75.73
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Ratio de endeudamiento
24.332024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Bueno
En 2024, el ratio de endeudamiento de PHARMACIE DELANGE METAYER (24.33) se sitúa por debajo de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Esta posición controlada refleja una gestión prudente.
Autonomía financiera
75.73%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excelente
En 2024, el autonomía financiera de PHARMACIE DELANGE METAYER (75.7%) se sitúa en el top 25% del sector. Este ratio representa la parte del patrimonio en la financiación total. Alta autonomía refleja independencia financiera y capacidad para absorber choques.
Liquidity ratios
El ratio de liquidez se sitúa en 312.54. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
207.052
221.439
240.902
236.315
256.939
324.568
183.69
312.54
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Ratio de liquidez
312.542024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excelente
En 2024, el ratio de liquidez de PHARMACIE DELANGE METAYER (312.54) se sitúa en el top 25% del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Un ratio superior a 1 asegura cobertura cómoda de vencimientos a corto plazo.
Positioning of PHARMACIE DELANGE METAYER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DELANGE METAYER is estimated at
2 622 245 €
(range 1 826 090€ - 3 923 029€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1826k€2622k€3923k€
2 622 245 €Range: 1 826 090€ - 3 923 029€
NAF 5 année 2024
Valuation method used
Net Income Multiple
187 830 €
×
14.0x
=2 622 246 €
Range: 1 826 090€ - 3 923 030€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DELANGE METAYER with other companies in the same sector:
Frequently asked questions about PHARMACIE DELANGE METAYER
What is the revenue of PHARMACIE DELANGE METAYER ?
The revenue of PHARMACIE DELANGE METAYER is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DELANGE METAYER profitable?
Yes, PHARMACIE DELANGE METAYER generated a net profit of 188 k€ in 2024.
Where is the headquarters of PHARMACIE DELANGE METAYER ?
The headquarters of PHARMACIE DELANGE METAYER is located in GROIX (56590), in the department Morbihan.
Where to find the tax return of PHARMACIE DELANGE METAYER ?
The tax return of PHARMACIE DELANGE METAYER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DELANGE METAYER operate?
PHARMACIE DELANGE METAYER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart